RU97111692A - Ointment with human interferon leukocyte "INTERON" - Google Patents

Ointment with human interferon leukocyte "INTERON"

Info

Publication number
RU97111692A
RU97111692A RU97111692/14A RU97111692A RU97111692A RU 97111692 A RU97111692 A RU 97111692A RU 97111692/14 A RU97111692/14 A RU 97111692/14A RU 97111692 A RU97111692 A RU 97111692A RU 97111692 A RU97111692 A RU 97111692A
Authority
RU
Russia
Prior art keywords
interon
ointment
leukocyte
interferon
human interferon
Prior art date
Application number
RU97111692/14A
Other languages
Russian (ru)
Other versions
RU2141819C1 (en
Inventor
Л.В. Волкова
В.Ф. Петров
Original Assignee
Пермское научно-производственное объединение "Биомед"
Filing date
Publication date
Application filed by Пермское научно-производственное объединение "Биомед" filed Critical Пермское научно-производственное объединение "Биомед"
Priority to RU97111692/14A priority Critical patent/RU2141819C1/en
Priority claimed from RU97111692/14A external-priority patent/RU2141819C1/en
Publication of RU97111692A publication Critical patent/RU97111692A/en
Application granted granted Critical
Publication of RU2141819C1 publication Critical patent/RU2141819C1/en

Links

Claims (1)

Мазь с интерфероном человеческим лейкоцитарным "Интерон" для лечении вирусных, бактериальных и хламидийных инфекций, содержащая вещество из группы интерферона и основу, отличающаяся тем, что в качестве вещества из группы интерферонов используют человеческий лейкоцитарный интерферон очищенный, а основой является вазелин, ПАВ и вода, где в качестве ПАВ используют эмульгатор T-2 или моноглицериды дистиллированные при следующем соотношении компонентов, г:
Человеческий лейкоцитарный интерферон очищенный - 2400-12000 ME
Вазелин - 0,6
Поверхностно-активные вещества (ПАВ) - 0,01-0,10
Вода дистиллированная - 0,39-0,30An ointment with human leukocyte interferon "Interon" for the treatment of viral, bacterial and chlamydial infections, containing a substance from the interferon group and a base, characterized in that the human leukocyte interferon is purified as a substance from the interferon group, and the basis is vaseline, surfactant and water, where T-2 emulsifier is used as a surfactant or distilled monoglycerides in the following ratio of components, g:
Human leukocyte interferon purified - 2400-12000 ME
Vaseline - 0.6
Surfactants (surfactants) - 0.01-0.10
Distilled water - 0.39-0.30
RU97111692/14A 1997-07-15 1997-07-15 Ointment with human leukocytic interferon "interon" RU2141819C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU97111692/14A RU2141819C1 (en) 1997-07-15 1997-07-15 Ointment with human leukocytic interferon "interon"

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU97111692/14A RU2141819C1 (en) 1997-07-15 1997-07-15 Ointment with human leukocytic interferon "interon"

Publications (2)

Publication Number Publication Date
RU97111692A true RU97111692A (en) 1999-06-10
RU2141819C1 RU2141819C1 (en) 1999-11-27

Family

ID=20195157

Family Applications (1)

Application Number Title Priority Date Filing Date
RU97111692/14A RU2141819C1 (en) 1997-07-15 1997-07-15 Ointment with human leukocytic interferon "interon"

Country Status (1)

Country Link
RU (1) RU2141819C1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2539383C1 (en) * 2013-11-29 2015-01-20 Закрытое акционерное общество "ФИРН М" (ЗАО "ФИРН М") Pharmaceutical composition for treating trophic ulcers and persistent wounds of various origins in form of ointment
RU2538699C1 (en) * 2013-11-29 2015-01-10 Закрытое акционерное общество "ФИРН М" (ЗАО "ФИРН М") Pharmaceutical composition for treating individuals suffering xerostomia

Similar Documents

Publication Publication Date Title
ATE73347T1 (en) ANTIVIRAL IMMUNOTHERAPEUTIC AGENT AND ITS PRODUCTION.
DE69535047D1 (en) L-nucleosides for the treatment of hepatitis B and Epstein-Bar virus
BG99261A (en) Steroid glycosides for the treatment of hyperchlesterolemia
DE69104777D1 (en) Oral drug forms of biologically active proteins.
CA2293470A1 (en) Benzimidazole derivatives
OA09498A (en) "Use of baclofen for obtaining medicaments intended for the treatment of angina pectoris".
ATE203415T1 (en) ORAL ADMINISTRATION SYSTEM OF CHEMICALLY MODIFIED PROTEINS G-CSF
DK403187A (en) TRANSDERMAL TAX PREPARATION
RU97111692A (en) Ointment with human interferon leukocyte "INTERON"
FR2689398B1 (en) Compositions for the treatment of hepatitis B virus (HBV) infection and diseases.
RU96115137A (en) APPLICATION OF DIMETICON FOR TREATMENT OF AFT AND STOMATITIS
DE69004451D1 (en) Prophylaxis and treatment of herpes virus infections.
BR9710377A (en) Orally administered hexahydropyrazine derivatives granules
DE69718911D1 (en) INTERLEUKIN - 8 AS ANTIVIRAL AND ANTITUARY ACTIVE SUBSTANCES
EP0655919A4 (en) Treatment of human viral infections.
RU98100616A (en) COMBINED CHEMOTHERAPEUTIC MEANS "BUTOL" FOR TREATMENT OF LOCAL WOUND INFECTION AND INFLAMMATORY DISEASES
RU99102949A (en) PREPARATION "ANTIGRIPPIN"
DK0459176T3 (en) Oligophosphates with antiviral action
BR0109345A (en) Compounds with anti-HIV activity
RU95114631A (en) MEANS FOR TREATING DISEASES COLI-INFECTED
FR2721315B1 (en) Guanylic acid derivatives and applications as medicaments.
ITMI910610U1 (en) MOBILE PURIFIER FOR SUCTION AND PURIFICATION OF TOXIC VAPORS
TH14396EX (en) toothbrush
RU96102608A (en) PHARMACEUTICAL PRODUCT FOR IMMUNOMODULATION AND ADJUVANT (FROM ENGLISH ADJUVANT) TREATMENT
RU97107046A (en) OIL "ANIKOL" FOR THE TREATMENT OF THE RAS, INFLAMMATORY AND SKIN DISEASES IN ANIMALS